Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Mar 28;27(6):653–659. doi: 10.1158/1055-9965.EPI-17-0905

Table 4.

Association of STC1 or STC2 expression with time to recurrence, ER+/TAM+ patient group.

Biomarker Expressiona Intercept (SE) Effect Estimate (β), median time to recurrence (SE)b 95% CI around β P valuec
STC1 −0.55 (0.41) 0.16 (0.10) −0.03, 0.36 0.20
STC2 −0.45 (0.36) 0.04 (0.09) −0.14, 0.21 0.71

SE=standard error

a

Expression of STC1 and STC2 dichotomized as positive (>0%) or negative (0%).

b

Median time to recurrence assessed at i=5 midpoints, by year.

c

Testing β=0.